These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8093562)

  • 21. v-erbA cooperates with bFGF in neuroretina cell transformation.
    Garrido C; Li RP; Samarut J; Gospodarowicz D; Saule S
    Virology; 1993 Feb; 192(2):578-86. PubMed ID: 7678474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ErbA: tumor suppressor turned oncogene?
    Damm K
    FASEB J; 1993 Jul; 7(10):904-9. PubMed ID: 8102105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Excision of Ets by an inducible site-specific recombinase causes differentiation of Myb-Ets-transformed hematopoietic progenitors.
    Rossi F; McNagny KM; Logie C; Stewart AF; Graf T
    Curr Biol; 1996 Jul; 6(7):866-72. PubMed ID: 8805301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence-specific DNA binding by the v-erbA oncogene protein of avian erythroblastosis virus.
    Bonde BG; Privalsky ML
    J Virol; 1990 Mar; 64(3):1314-20. PubMed ID: 1968105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha.
    Damm K; Evans RM
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10668-72. PubMed ID: 7902566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the different RAR isoforms in controlling the erythrocytic differentiation sequence. Interference with the v-erbA and p135gag-myb-ets nuclear oncogenes.
    Gandrillon O; Samarut J
    Oncogene; 1998 Feb; 16(5):563-74. PubMed ID: 9482102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissecting the activating mutations in v-erbB of avian erythroblastosis virus strain R.
    Shu HK; Pelley RJ; Kung HJ
    J Virol; 1991 Nov; 65(11):6173-80. PubMed ID: 1681117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional interaction between the two zinc finger domains of the v-erb A oncoprotein.
    Hall BL; Bonde BG; Judelson C; Privalsky ML
    Cell Growth Differ; 1992 Apr; 3(4):207-16. PubMed ID: 1355356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional repression of band 3 and CAII in v-erbA transformed erythroblasts accounts for an important part of the leukaemic phenotype.
    Fuerstenberg S; Leitner I; Schroeder C; Schwarz H; Vennström B; Beug H
    EMBO J; 1992 Sep; 11(9):3355-65. PubMed ID: 1354613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cooperation of v-jun and v-erbB oncogenes in embryo fibroblast transformation in vitro and in vivo.
    Garcia M; Samarut J
    J Virol; 1990 Oct; 64(10):4684-90. PubMed ID: 1975843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FH3, a v-myc avian retrovirus with limited transforming ability.
    Chen C; Biegalke BJ; Eisenman RN; Linial ML
    J Virol; 1989 Dec; 63(12):5092-100. PubMed ID: 2555545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The leukaemia oncogene v-erbA: a dominant negative version of ligand dependent transcription factors that regulates red cell differentiation?
    Ghysdael J; Beug H
    Cancer Surv; 1992; 14():169-80. PubMed ID: 1358441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single point mutation in erbA restores the erythroid transforming potential of a mutant avian erythroblastosis virus (AEV) defective in both erbA and erbB oncogenes.
    Damm K; Beug H; Graf T; Vennström B
    EMBO J; 1987 Feb; 6(2):375-82. PubMed ID: 2884103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the v-erbA product, an altered nuclear hormone receptor, is sufficient to transform erythrocytic cells in vitro.
    Gandrillon O; Jurdic P; Pain B; Desbois C; Madjar JJ; Moscovici MG; Moscovici C; Samarut J
    Cell; 1989 Jul; 58(1):115-21. PubMed ID: 2568887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.
    Ciana P; Braliou GG; Demay FG; von Lindern M; Barettino D; Beug H; Stunnenberg HG
    EMBO J; 1998 Dec; 17(24):7382-94. PubMed ID: 9857194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The lack of transcriptional activation of the v-erbA oncogene is in part due to a mutation present in the DNA binding domain of the protein.
    de Verneuil H; Metzger D
    Nucleic Acids Res; 1990 Aug; 18(15):4489-97. PubMed ID: 1975094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. V-erbA requires auxiliary proteins for dominant negative activity.
    Hermann T; Hoffmann B; Piedrafita FJ; Zhang XK; Pfahl M
    Oncogene; 1993 Jan; 8(1):55-65. PubMed ID: 8093812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EGF-R as a hemopoietic growth factor receptor: the c-erbB product is present in chicken erythrocytic progenitors and controls their self-renewal.
    Pain B; Woods CM; Saez J; Flickinger T; Raines M; Peyrol S; Moscovici C; Moscovici MG; Kung HJ; Jurdic P
    Cell; 1991 Apr; 65(1):37-46. PubMed ID: 1672832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transformation of chicken bone marrow cells by the v-ski oncogene.
    Larsen J; Meyer S; Steinlein P; Beug H; Hayman MJ
    Oncogene; 1993 Dec; 8(12):3221-8. PubMed ID: 7504231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A subpopulation of the avian erythroblastosis virus v-erbA protein, a member of the nuclear hormone receptor family, is glycosylated.
    Privalsky ML
    J Virol; 1990 Jan; 64(1):463-6. PubMed ID: 1967151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.